edited by Jeffrey S. Chamberlain, Thomas A. Rando.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
New York
Name of Publisher, Distributor, etc.
Taylor & Francis
Date of Publication, Distribution, etc.
2006
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
(xxii, 461 pages) : illustrations.
SERIES
Series Title
Neurological disease and therapy, v. 79.
CONTENTS NOTE
Text of Note
Front Cover; Preface; Contents; Introduction; 1. Clinical Overview of Duchenne Muscular Dystrophy; 2. The Functional Biology of Dystrophin: Structural Components and the Pathogenesis of Duchenne Muscular Dystrophy; 3. The Functional Biology of Dystrophin: Associated Signaling Pathways and Potential Targets for Therapeutic Intervention; 4. Duchenne Muscular Dystrophy and Becker Muscular Dystrophy: Diagnostic Principles; 5. Mutation Detection; 6. Protein Studies in Duchenne Muscular Dystrophy; 7. Medical Management of Duchenne Muscular Dystrophy.
SUMMARY OR ABSTRACT
Text of Note
Duchenne Muscular Dystrophy (DMD) is one of the most prevalent genetic disorders of childhood and currently stands as an incurable condition. This authoritative guide provides a clear overview of the latest current and experimental approaches to the treatment of DMD and examines the clinical, genetic, and pathophysiological aspects of the disease in the context of emerging therapeutic modalities. The only available source on the subject, this reference emphasizes the importance of accurate diagnosis, carrier detection, and genetic counseling, and supplies state-of-the-art contributions on phar.
TOPICAL NAME USED AS SUBJECT
Duchenne muscular dystrophy -- Treatment.
Duchenne, Myopathie de -- Traitement.
MEDICAL -- Orthopedics.
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RJ482
.
D78
Book number
E358
2006
PERSONAL NAME - PRIMARY RESPONSIBILITY
edited by Jeffrey S. Chamberlain, Thomas A. Rando.